Company Regencell Bioscience Holdings Limited

Equities

RGC

KYG7487R1002

Biotechnology & Medical Research

Market Closed - Nasdaq 21:30:00 09/05/2024 BST 5-day change 1st Jan Change
5.56 USD -10.61% Intraday chart for Regencell Bioscience Holdings Limited +4.32% -47.05%

Business Summary

Regencell Bioscience Holdings Ltd is a bioscience company that focuses on research, development and commercialization of traditional Chinese medicine (TCM) for the treatment of neurocognitive disorders and degeneration, specifically attention deficit and hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). The Company launches three liquid based standardized TCM formulae candidates for mild, moderate and severe ADHD and ASD patients.

Number of employees: 12

Managers

Managers TitleAgeSince
Chief Operating Officer 46 -
Chief Tech/Sci/R&D Officer 59 30/09/20
Corporate Officer/Principal - -
- -

Members of the board

Members of the board TitleAgeSince
Director/Board Member 63 12/12/21
Chief Tech/Sci/R&D Officer 59 30/09/20
- -
Director/Board Member 51 -
Director/Board Member 53 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 13,012,866 1,462,370 ( 11.24 %) 0 11.24 %

Shareholders

NameEquities%Valuation
Digital Mobile Venture Ltd.
7.599 %
988,902 7.599 % 4 M $
UBS Securities LLC
0.1234 %
16,053 0.1234 % 72 239 $
BlackRock Financial Management, Inc.
0.001829 %
238 0.001829 % 1 071 $
Qube Research & Technologies Ltd. (France)
0.000100 %
13 0.000100 % 59 $

Company contact information

Regencell Bioscience Holdings Ltd.

Chinachem Leighton Plaza 29 Leighton Road

, Hong Kong

+

http://www.regencellbioscience.com
address Regencell Bioscience Holdings Limited(RGC)
  1. Stock Market
  2. Equities
  3. RGC Stock
  4. Company Regencell Bioscience Holdings Limited